A lot of people ask us for this particular information but not everybody with cancer is willing to read it. So, if you are not sure whether you want to find out at the moment, you can freely come back to it later on. These are the general statistics which are based on massive groups of patients. They cannot tell you what will occur in your individual case. No one can actually tell you precisely how long you will live with the cancer. It dramatically depends on your individual situation, level of physical fitness, and medical treatment. Presumably your doctor can give you more information about your own prognosis or outlook. Or perhaps you can simply talk to experts or specialists on lung cancer.
The Survival Rates for Non-Small-Cell Lung Cancer by Stages
There are actually no UK-wide statistics available for non-small-cell lung cancer survival. The following statistics originate from the 2007 Lung Cancer Staging endeavour. This global-level study gathered data regarding lung cancer on more than 80,000 patients from over 19 countries. There is a range of statistics for every stage since for some patients the stage was solely based on the outcomes of tests and scans, and for others the stage was found during the surgical procedure. So it is actually hard to reveal the precise stage of the lung cancer. In addition, the disease is commonly detected when the cancer has reached the later stage of the disease.
At the first stage, the non-small cell lung cancer is typically divided into a couple of stages, which constitute stage 1A and 1 B. For stage 1A, non-small cell lung cancer, between 58 and 73 out of every a hundred of people will survive five years or more subsequent to the prognosis. For stage 1B, non-small cell lung cancer, between 43 and 58 out of every a hundred of people are estimated to survive 5 years or even more after the diagnosis.
Reaching the stage 2, non-small cell lung cancer, between 36 and 46 out of a hundred of people will survive for five years or even more with treatment. Actually the second stage also comprises of 2B at which between 25 and 36 out of every a hundred of people will survive for five years or more after the diagnosis. At the stage 3, non-small cell lung cancer is divided into stage 3A and 3B. For stage 3A, the non-small lung cancer, between 19 and 24 out of every a hundred of people survive for five years or more after they have been diagnosed. For stage 4, non-small cell lung cancer, only between 2 and 13 out of a hundred of people survive 5 years or even more after they are diagnosed.
It can appear illogical for stage 3B cancer to have five year survival rates from 7% to 9% and the fourth stage from 2% to 13%. This is due to the fact that staging system only focuses on the extent of the cancer. It does not deal with the specific types of cancer. So the fourth stage group may include more and more people that have slowly growing cancers or even cancers which respond very well to certain treatments than does the stage 3 group.
